Vascularized organ bioprinting: From strategy to paradigm
Cell Proliferation · 2023-05 · 56 (5)
DOI: 10.1111/cpr.13453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 16.03.2023. Verfasst von Heran Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China. Hauptthemen laut MEDLINE: Tissue Engineering, Bioprinting. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Foundation of State Key Laboratory of Robotics, The National Key Research and Development Program of China.
Abstract (Originalsprache)
Over the past two decades, 3D bioprinting has become a popular research topic worldwide, as it is the most promising approach for manufacturing vascularized organs in vitro. However, transitioning from bioprinting of simple tissue models to real biomedical applications is still a challenge due to incomplete interdisciplinary theoretical knowledge and imperfect multi‐technology integration. This review examines the goals of vasculature manufacturing and proposes new strategic objectives in three stages. We then outline a bidirectional manufacturing strategy consisting of top‐down reconstruction (bioprinting) and bottom‐up regeneration (cellular behaviour). We also provide an in‐depth analysis of the four aspects of design, ink, printing and culture. Furthermore, we present the ‘construction‐comprehension cycle’ research paradigm and the ‘math‐model‐based batch insights generator’ research paradigm for the future, which may have the potential to revolutionize the biomedical field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China.
- Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, China.
- University of Chinese Academy of Sciences, Beijing, China.
- State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Heran Wang, Xin Liu, Qi Gu, Xiongfei Zheng
Förderung
- National Natural Science Foundation of China
- The Foundation of State Key Laboratory of Robotics
- The National Key Research and Development Program of China
- The Research Equipment Development Program of CAS
- The Strategic Priority Research Program of CAS
- CAS Project for Young Scientists in Basic Research
Zitieren
APA
Wang, H., Liu, X., Gu, Q., & Zheng, X. (2023). Vascularized organ bioprinting: From strategy to paradigm. Cell Proliferation, 56(5). https://doi.org/10.1111/cpr.13453
Vancouver
Wang H, Liu X, Gu Q, Zheng X. Vascularized organ bioprinting: From strategy to paradigm. Cell Proliferation. 2023;56(5). doi:10.1111/cpr.13453
BibTeX
@article{Wang2023,
author = {Wang, Heran and Liu, Xin and Gu, Qi and Zheng, Xiongfei},
title = {Vascularized organ bioprinting: From strategy to paradigm},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {5},
doi = {10.1111/cpr.13453}
}
EUVIMED